Company intelligence / Profile preview

MyBiotech

Überherrn, Saarland, Germanymybiotech.de ↗

Ownership: Private
Development stage: Commercial

Overview

MyBiotech is a leading European CDMO specializing in the development and GMP manufacturing of innovative biotechnological and pharmaceutical products. The company has proprietary technologies for cell disruption and purification, with a strong track record in nanoparticle/microparticle formulation development. It offers end-to-end services from R&D to commercial-scale production for both biotech ingredients and pharmaceuticals.

Modalities: Small moleculeNanoparticleMicroparticleBiologic (including algae-derived Omega‑3 fatty acids, curcumin, phycocyanin)
Industry: Contract Manufacturing Organization

Partnerships

Over 120 cooperation partners worldwide including academic institutions and industry consortia in Europe

Beyond the preview

Go deeper on MyBiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyBiotech.

Explore the full profile